We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page.
Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site.
(Oslo, 20 July 2020) Notice of exercise of employee share options In connection with the expiry date at 31 March 2020, postponed by the Board of Directors to no later than 30 September 2020, Kathrine Gamborg Andreassen, board member, have at 20 July 2020 given notice that she will exercise a total of 125,000 options…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read moreReference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue"). Navamedic ASA ("NAVA"), represented at the Company's…
Read moreAnnual Report
Quarterly Presentation – Q1
Annual General Meeting
Half-yearly Report
Quarterly Presentation – Q3
Last updated 3 August 2020
| Name | Number of shares | % of top 20 | % of total | Country | |
|---|---|---|---|---|---|
| 1 | NAVAMEDIC ASA | 4,222,727 | 26.02% | 21.73% | Norway |
| 2 | INGERØ REITEN INV. COMPANY AS | 3,939,394 | 24.28% | 20.27% | Norway |
| 3 | RO, LARS | 1,450,000 | 8.94% | 7.46% | NORWAY |
| 4 | UBS SWITZERLAND AG | 1,420,522 | 8.75% | 7.31% | SWITZERLAND |
| 5 | ARTAL AS | 858,951 | 5.29% | 4.42% | Norway |
| 6 | ALPINE CAPITAL AS | 645,000 | 3.97% | 3.32% | Norway |
| 7 | NORDA ASA | 516,570 | 3.18% | 2.66% | Norway |
| 8 | TRANBERGKOLLEN INVEST AS | 500,000 | 3.08% | 2.57% | Norway |
| 9 | LEIKERANE AS | 466,666 | 2.88% | 2.40% | Norway |
| 10 | SOLEGLAD INVEST AS | 461,668 | 2.85% | 2.38% | Norway |
| 11 | LAPAS AS | 336,924 | 2.08% | 1.73% | Norway |
| 12 | MP PENSJON PK | 262,025 | 1.61% | 1.35% | NORWAY |
| 13 | KRAEBER VERWALTUNG GMBH | 214,850 | 1.32% | 1.11% | GERMANY |
| 14 | VICAMA AS | 201,266 | 1.24% | 1.04% | Norway |
| 15 | BUKKEVIK INVESTERING AS | 140,000 | 0.86% | 0.72% | SWEDEN |
| 16 | GINNY INVEST AS | 128,894 | 0.79% | 0.66% | Norway |
| 17 | BJØRNTVEDT, EIVIND | 124,153 | 0.77% | 0.64% | Norway |
| 18 | BJØRNTVEDT, VEGARD | 119,358 | 0.74% | 0.61% | Norway |
| 19 | NORDNET BANK AB | 113,549 | 0.70% | 0.58% | Norway |
| 20 | EILERAAS, KARL ANSGAR | 104,491 | 0.64% | 0.54% | Norway |
| Total numBer owned by top 20 | 16,227,098 | 100.00% | 83.50% | ||
| Total number of shares | 19,433,582 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Oslo Axess
OBSERV
4 November 2019
Healthcare
NOK
NO0010865009
15 342 673
NOK 0.26
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bernt Olav Røttingsnes (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com